Health
Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co. – News-Medical.net
Horizon Discovery today announced that it has granted commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou will use Horizon’s gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster…
-
Business16 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News20 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’